珠海润都制药股份有限公司 第五届董事会第十四次会议 决议公告

Group 1 - The company held its 14th meeting of the 5th Board of Directors on October 14, 2025, with all 7 directors present [2][4] - The Board approved the proposal to amend the Articles of Association, which will be submitted to the shareholders' meeting for approval [3][5] - The Board also approved the proposal to revise and establish certain governance systems, including renaming existing rules and creating new management systems [6][7] Group 2 - The company scheduled the 2025 Second Extraordinary General Meeting of Shareholders for October 31, 2025, at 14:30 [8][12] - The meeting will combine on-site voting and online voting, with specific time slots for network voting [15][22] - The company will ensure that the voting results for minority investors will be counted separately [18]